EX-10.34 3 exhibit1034.htm EXHIBIT 10.34
Exhibit 10.34
On January 31, 2017, the Board of Directors of SCYNEXIS, Inc. took the following compensation actions with respect to SCYNEXIS’s following executive officers (collectively, the “Officers”):
2016 Officer Bonuses
Approved cash bonuses for the Officers based on SCYNEXIS’s performance for the calendar year 2016:

Executive Officer |  | Title |  | Bonus
Marco Taglietti, M.D. |  | Chief Executive Officer |  | $210,100
David Angulo, M.D. |  | Chief Medical Officer |  | $136,600
Eric Francois |  | Chief Financial Officer |  | $113,000

2017 Salaries
Approved the 2017 salaries for the Officers, to be effective March 1, 2017, as follows:

Executive Officer |  | Title |  | 2017 Salary
Marco Taglietti, M.D. |  | Chief Executive Officer |  | $510,000
David Angulo, M.D. |  | Chief Medical Officer |  | $413,800
Eric Francois |  | Chief Financial Officer |  | $360,500

Option Grants
Approved stock option grants under SCYNEXIS 's 2014 Equity Incentive Plan to the following Officers:

Executive Officer |  | Title |  | Shares subject to Option
Marco Taglietti, M.D. |  | Chief Executive Officer |  | 360,000
David Angulo, M.D. |  | Chief Medical Officer |  | 140,000
Eric Francois |  | Chief Financial Officer |  | 100,000

The options have an exercise price of $3.02 per share and vest on a monthly basis over a four-year period, provided such officer is continuing to provide services to SCYNEXIS on such vesting date.